Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peiwei Li

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2014
Diagnostic and prognostic value of microRNA-21 in colorectal cancer: an original study and individual participant data meta-analysisHonghe Zhang, Peiwei Li, Haixing Ju, et al.
Cancer Discovery|January 9, 2026
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical CancerChunyan Lan, Peidong Zhang, Jing Zhao, et al.
Cancer Discovery|November 26, 2025
Molecular and immune correlates of response to first-line de-escalated chemotherapy plus penpulimab and anlotinib in advanced cervical cancerQin Xu, Zhengrong Deng, Jing Liu, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2014
Diagnostic and prognostic value of microRNA-21 in colorectal cancer: an original study and individual participant data meta-analysisHonghe Zhang, Peiwei Li, Haixing Ju, et al.
Cancer Discovery|January 9, 2026
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical CancerChunyan Lan, Peidong Zhang, Jing Zhao, et al.
Cancer Discovery|November 26, 2025
Molecular and immune correlates of response to first-line de-escalated chemotherapy plus penpulimab and anlotinib in advanced cervical cancerQin Xu, Zhengrong Deng, Jing Liu, et al.
Pageof 7